Fahd Al-Mulla
Fahd Al-Mulla
Dasman Diabetes Institute
Verified email at al-mulla.org - Homepage
Title
Cited by
Cited by
Year
Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’study
HJN Andreyev, AR Norman, D Cunningham, J Oates, BR Dix, ...
British journal of cancer 85 (5), 692-696, 2001
9232001
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database
BA Thompson, AB Spurdle, JP Plazzer, MS Greenblatt, K Akagi, ...
Nature genetics 46 (2), 107-115, 2014
3452014
Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis
S Hagan, F Al-Mulla, E Mallon, K Oien, R Ferrier, B Gusterson, JJC García, ...
Clinical Cancer Research 11 (20), 7392-7397, 2005
2952005
KRAS and BRAF oncogenic mutations in MSS colorectal carcinoma progression
C Oliveira, S Velho, C Moutinho, A Ferreira, A Preto, E Domingo, ...
Oncogene 26 (1), 158-163, 2007
2502007
Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts
M Pupo, A Pisano, R Lappano, MF Santolla, EM De Francesco, ...
Environmental health perspectives 120 (8), 1177-1182, 2012
2152012
A review of non-invasive techniques to detect and predict localised muscle fatigue
MR Al-Mulla, F Sepulveda, M Colley
Sensors 11 (4), 3545-3594, 2011
2062011
Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes
MS Bitar, S Wahid, S Mustafa, E Al-Saleh, GS Dhaunsi, F Al-Mulla
European journal of pharmacology 511 (1), 53-64, 2005
2052005
ENIGMA—evidence‐based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with …
AB Spurdle, S Healey, A Devereau, FBL Hogervorst, ANA Monteiro, ...
Human mutation 33 (1), 2-7, 2012
2032012
Pathogenic germline variants in 10,389 adult cancers
K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ...
Cell 173 (2), 355-370. e14, 2018
1932018
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
WH Goodson III, L Lowe, DO Carpenter, M Gilbertson, A Manaf Ali, ...
Carcinogenesis 36 (Suppl_1), S254-S296, 2015
1922015
Raf kinase inhibitor protein expression in a survival analysis of colorectal cancer patients
F Al-Mulla, S Hagan, AI Behbehani, MS Bitar, SS George, JJ Going, ...
Journal of Clinical Oncology 24 (36), 5672-5679, 2006
1902006
The order of genetic events associated with colorectal cancer progression inferred from meta‐analysis of copy number changes
CB Diep, K Kleivi, FR Ribeiro, MR Teixeira, OC Lindgjærde, RA Lothe
Genes, Chromosomes and Cancer 45 (1), 31-41, 2006
1882006
Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer
G Ren, S Baritaki, H Marathe, J Feng, S Park, S Beach, PS Bazeley, ...
Cancer research 72 (12), 3091-3104, 2012
1852012
Comparative genomic hybridization analysis of primary colorectal carcinomas and their synchronous metastases
F Al‐Mulla, WN Keith, IR Pickford, JJ Going, GD Birnie
Genes, Chromosomes and Cancer 24 (4), 306-314, 1999
1571999
Heterogeneity of mutant versus wild‐type Ki‐ras in primary and metastatic colorectal carcinomas, and association of codon‐12 valine with early mortality
F Al‐Mulla, JJ Going, ETHH Sowden, A Winter, IR Pickford, GD Birnie
The Journal of Pathology: A Journal of the Pathological Society of Great …, 1998
1341998
Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells
S Al Saleh, F Al Mulla, YA Luqmani
PloS one 6 (6), e20610, 2011
1162011
Raf kinase inhibitor protein RKIP enhances signaling by glycogen synthase kinase-3β
F Al-Mulla, MS Bitar, M Al-Maghrebi, AI Behbehani, W Al-Ali, O Rath, ...
Cancer Research 71 (4), 1334-1343, 2011
1112011
Environmental immune disruptors, inflammation and cancer risk
PA Thompson, M Khatami, CJ Baglole, J Sun, SA Harris, EY Moon, ...
Carcinogenesis 36 (Suppl_1), S232-S253, 2015
1102015
Causes of genome instability: the effect of low dose chemical exposures in modern society
SAS Langie, G Koppen, D Desaulniers, F Al-Mulla, R Al-Temaimi, ...
Carcinogenesis 36 (Suppl_1), S61-S88, 2015
1082015
Global implementation of genomic medicine: we are not alone
TA Manolio, M Abramowicz, F Al-Mulla, W Anderson, R Balling, ...
Science translational medicine 7 (290), 290ps13-290ps13, 2015
1072015
The system can't perform the operation now. Try again later.
Articles 1–20